Accessibility Menu
Aurora Spine logo

Aurora Spine(TSXV) ASG

Current PriceCA$0.21
Market CapCA$16.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-85%
5 Year-71%
1 Year-40%
1 Month-11%
Aurora Spine last closing stock price
MetricPriceDate
Last closeCAD 0.212026-07-23
Aurora Spine stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-12.77%CAD 0.242026-07-16
1 month-10.87%CAD 0.232026-06-22
3 month-25.45%CAD 0.282026-04-24
Year to date-24.07%CAD 0.272025-12-31
1 year-39.71%CAD 0.342025-07-23
3 year-19.61%CAD 0.262023-07-24
5 year-71.13%CAD 0.712021-07-22
Since inception-84.81%CAD 1.352013-09-11

Aurora Spine Financials at a Glance

Market Cap

CA$16.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$18.31M

Net Income (TTM)

-$593.77K

EPS (TTM)

-CA$0.01

P/E Ratio

-19.90

Dividend

CA$0.00

Beta (Volatility)

0.44 (Low)

Price

CA$0.21

Volume

3,500

Open

CA$0.21

Previous Close

CA$0.21

Daily Range

CA$0.21 - CA$0.21

52-Week Range

CA$0.21 - CA$0.35

Estimated Earnings Date

May 27, 2026

ASG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aurora Spine

Aurora Spine Corporation, established in 2013 and headquartered in Toronto, Canada, specializes in the development and distribution of advanced, minimally invasive spinal fusion systems and devices. The company focuses on addressing various spinal conditions, particularly degenerative disc diseases, through a comprehensive portfolio of innovative products.

Products and Services
  • Interspinous process lumbar fusion devices, including the ZIP series
  • Ti-Coated polyether ether ketone (PEEK) interbody cages for spinal stability
  • 3D-printed spinal fusion implants, such as the DEXA-C cervical interbody system
Growth Outlook
  • Increasing demand for minimally invasive spinal procedures supports growth potential
  • Expansion of product offerings enhances market competitiveness
  • Strategic partnerships may drive future revenue growth
Financial Highlights
  • Recent quarterly revenue of 4.36 million, showing resilience in a challenging market
  • Trailing twelve months (TTM) gross profit margin of 52.4%, indicating strong product demand
  • Current ratio of 2.53 suggests solid liquidity position
Aurora Spine Corporation is positioned within the healthcare sector, focusing on innovative spinal solutions. The company’s product range addresses critical needs in spinal health, particularly for patients suffering from degenerative conditions. The growth outlook remains positive, driven by increasing demand for minimally invasive procedures and the potential for strategic partnerships. Financially, the company has demonstrated resilience, with a notable gross profit margin and a strong liquidity position, which may appeal to potential investors looking for opportunities in the medical devices industry.
AI Generated • Jul 23, 2026

Industry

Healthcare Equipment and Supplies

CEO

Trent J. Northcutt

Headquarters

Toronto, ON M4S 3B1, CA

ASG Financials

Key Financial Metrics (TTM)

Gross Margin

52.44%

Operating Margin

-1.19%

Net Income Margin

-3.24%

Return on Equity

-15.61%

Return on Capital

-4.49%

Return on Assets

-6.11%

Earnings Yield

-5.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$16.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

78.09M

Volume

3.50K

Avg. Volume

30.18K

Financials (TTM)

Gross Profit

$9.60M

Operating Income

-$218.14K

EBITDA

$884.87K

Operating Cash Flow

$1.21M

Capital Expenditure

-$445.26K

Free Cash Flow

$764.08K

Cash & ST Invst.

$778.56K

Total Debt

$2.26M

Aurora Spine Performance Analysis

Aurora Spine annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 19,368,09646.5%
20232023-12-31USD 19,598,0431.2%
20242024-12-31USD 24,060,33722.8%
20252025-12-31USD 25,665,4366.7%
Aurora Spine sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-301.8%
Q32025-09-30-1.5%
Q42025-12-3113.4%
Q12026-03-31-13.1%
Aurora Spine annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.03-41.9%
20232023-12-31USD -0.039.6%
20242024-12-31USD -0.02-44.9%
20252025-12-31USD -0.01-26.0%
Aurora Spine sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3042.2%
Q32025-09-3030.8%
Q42025-12-3166.7%
Q12026-03-31-333.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$4.36M

-1.2%

Gross Profit

$967.57K

-62.2%

Gross Margin

22.18%

N/A

Market Cap

CA$16.01MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$1.23M

N/A

Employees

13

N/A

Net Income

-$199.53K

+42.9%

EBITDA

$92.31K

+337.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$778.56K

+59.3%

Total Debt

$2.26M

-38.6%

Accounts Receivable

$3.00M

-26.8%

Inventory

$3.21M

-15.8%

Long Term Debt

$1.93M

-42.7%

Short Term Debt

$330.96K

+4.6%

Return on Assets

-6.11%

N/A

Return on Invested Capital

-3.19%

N/A

Free Cash Flow

-$28.13K

+92.1%

Operating Cash Flow

-$12.64K

+92.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VPT.VVentriPoint Diagnostics Ltd.
CA$0.11-8.70%
BCT.TOBriaCell Therapeutics Corp.
CA$5.22+1.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
INTCIntel
$100.23-0.02%
AALAmerican Airlines Group
$13.56-0.08%
TAT&T
$22.96-0.00%

Questions About ASG

What is the current price of Aurora Spine?

Aurora Spine is trading at CA$0.21 per share.

What is the 52-week range for Aurora Spine?

Over the past 52 weeks, Aurora Spine has traded between CA$0.21 and CA$0.35.

How much debt does Aurora Spine have?

As of the most recent reporting period, Aurora Spine reported total debt of $3.15M.

How much cash does Aurora Spine have on hand?

Aurora Spine reported $1.09M in cash and cash equivalents in its most recent financial results.

What is Aurora Spine’s dividend yield?

Aurora Spine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.